Atlas Trials

Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants

Clinical trial NCT04944771 · COMPLETED

Trial details

NCT number
NCT04944771
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid and Hematological Malignancies
Start date
2021-07-26
Primary completion
2022-05-04
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.